Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2025-01-02 to 2025-01-03
Current total value of award: $200.4
Description: 4566866802!MIDAZOLAM HCL 5 MG/ML VIALML